By countering the adaptive response by the brain in response to the changes in gut hormone levels and reduction in leptin levels, obesity medications allow for homeostatic adipose mass regulation at a lower calorie intake and adipose mass set point [65, 66, 67]. This evidence concerns the gene LEP and obesity disorder.